| Literature DB >> 2530088 |
R Hauptmann1, I Maurer-Fogy, E Krystek, G Bodo, H Andree, C P Reutelingsperger.
Abstract
A cDNA was cloned coding for a new member of the human Ca2+-modulated phospholipid-binding protein family termed annexins. Due to its 56% identity to the human vascular anticoagulant (VAC) the new protein is named VAC-beta, renaming the previous VAC as VAC-alpha. Northern analysis detects one hybridizing mRNA species of 2.2 kb in human placenta. Genomic Southern blot analysis shows a VAC-beta gene of comparable complexity to the VAC-alpha gene. The cDNA was expressed in Escherichia coli and the recombinant protein purified to homogeneity. Antiserum raised against VAC-beta weakly cross-reacts with VAC-alpha. The properties of VAC-beta as an anticoagulant and as an inhibitor of phospholipase A2 activity were analyzed and compared to those of VAC-alpha.Entities:
Mesh:
Substances:
Year: 1989 PMID: 2530088 DOI: 10.1111/j.1432-1033.1989.tb15082.x
Source DB: PubMed Journal: Eur J Biochem ISSN: 0014-2956